Related Experiment Video

Updated: Oct 7, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.4K

Candida Pneumonia with Lung Abscess as a Complication of Severe COVID-19 Pneumonia

Adel Abdelhadi1, Abeer Kassem2

  • 1Department of Critical Care Medicine, Saqr Hospital, MOH, Ras Al-Khaimah, Ras Al-Khaimah, United Arab Emirates.

International Medical Case Reports Journal
|January 7, 2022
PubMed

Insights

This case study details a severe COVID-19 infection complicated by a rare pulmonary candida lung abscess in a patient with undiagnosed diabetes. Early recognition and multidisciplinary care led to successful recovery.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Pulmonology

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, or COVID-19, can present with diverse clinical manifestations.
  • Undiagnosed diabetes mellitus (DM) and opportunistic infections pose significant risks in COVID-19 patients.
  • Fungal lung abscesses are rare but serious complications, particularly in immunocompromised individuals.

Observation:

  • A middle-aged South Asian male with severe COVID-19 developed sepsis, hyperglycemia, and oral candidiasis.
  • The patient experienced a brain infarction and subsequently developed a necrotizing pulmonary candida lung abscess.
  • Clinical and radiological findings suggested COVID-19 prior to rtPCR confirmation.

Findings:

  • The patient's hyperglycemia and oral candidiasis were linked to the rare direct spread of Candida to the lungs, forming an abscess.
  • COVID-19 was associated with arteriovenous complications and this unique pulmonary fungal infection.
  • Prompt diagnosis and management of hyperglycemia and fungal infection were crucial.

Implications:

  • Early clinical and radiological assessment for COVID-19 is vital, especially in patients with hyperglycemia.
  • Interdisciplinary management in the emergency room and intensive care unit (ICU) improves outcomes for severe COVID-19.
  • This case underscores the potential for rare complications like pulmonary fungal abscesses in severe COVID-19 patients with metabolic derangements.
Keywords:
Candida albicanscomputed tomography scanmanagementremdesivir therapy

More Related Videos

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

9.0K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.7K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
515
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
384
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
914
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
491
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.6K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
388